Bryn Mawr Trust CO Eli Lilly & CO Transaction History

Bryn Mawr Trust CO

  • $5.88 Billion
  • Q3 2025

A detailed history of Bryn Mawr Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Bryn Mawr Trust CO holds 38,114 shares of LLY stock, worth $32.9 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
38,114
Previous 37,704 1.09%
Holding current value
$32.9 Million
Previous $29.4 Million 1.06%
% of portfolio
0.49%
Previous 0.53%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025
BUY
$625.65 - $812.69 $256,516 - $333,202
410 Added 1.09%
38,114 $29.1 Million
Q2 2025

Jul 28, 2025
SELL
$713.71 - $898.95 $1.27 Million - $1.61 Million
-1,786 Reduced 4.52%
37,704 $29.4 Million
Q1 2025

May 08, 2025
SELL
$725.72 - $929.72 $975,367 - $1.25 Million
-1,344 Reduced 3.29%
39,490 $32.6 Million
Q4 2024

Jan 28, 2025
BUY
$727.2 - $932.06 $566,488 - $726,074
779 Added 1.94%
40,834 $31.5 Million
Q3 2024

Nov 25, 2024
BUY
$772.14 - $960.02 $17.6 Million - $21.9 Million
22,840 Added 132.67%
40,055 $35.5 Million
Q2 2024

Aug 08, 2024
SELL
$724.87 - $909.04 $305,170 - $382,705
-421 Reduced 2.39%
17,215 $15.6 Million
Q1 2024

May 14, 2024
SELL
$592.2 - $792.28 $800,654 - $1.07 Million
-1,352 Reduced 7.12%
17,636 $13.7 Million
Q3 2023

Nov 15, 2023
SELL
$434.7 - $599.3 $103,458 - $142,633
-238 Reduced 1.24%
18,988 $10.2 Million
Q2 2023

Aug 11, 2023
SELL
$350.74 - $468.98 $251,129 - $335,789
-716 Reduced 3.59%
19,226 $9.02 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $364,679 - $428,298
-1,174 Reduced 5.56%
19,942 $6.85 Million
Q4 2022

Feb 10, 2023
SELL
$321.55 - $374.67 $168,170 - $195,952
-523 Reduced 2.42%
21,116 $7.73 Million
Q3 2022

Nov 14, 2022
SELL
$296.48 - $337.87 $40,914 - $46,626
-138 Reduced 0.63%
21,639 $7 Million
Q2 2022

Aug 11, 2022
SELL
$278.73 - $327.27 $765,950 - $899,337
-2,748 Reduced 11.2%
21,777 $7.06 Million
Q1 2022

May 16, 2022
SELL
$234.69 - $291.66 $97,161 - $120,747
-414 Reduced 1.66%
24,525 $7.02 Million
Q4 2021

Feb 10, 2022
SELL
$224.85 - $279.04 $35,976 - $44,646
-160 Reduced 0.64%
24,939 $6.89 Million
Q3 2021

Oct 26, 2021
SELL
$221.6 - $272.71 $263,260 - $323,979
-1,188 Reduced 4.52%
25,099 $5.8 Million
Q2 2021

Jul 29, 2021
BUY
$180.55 - $233.54 $70,775 - $91,547
392 Added 1.51%
26,287 $6.03 Million
Q1 2021

Apr 23, 2021
SELL
$164.32 - $212.72 $220,188 - $285,044
-1,340 Reduced 4.92%
25,895 $4.84 Million
Q4 2020

Feb 11, 2021
SELL
$130.46 - $172.63 $214,867 - $284,321
-1,647 Reduced 5.7%
27,235 $4.6 Million
Q3 2020

Nov 12, 2020
SELL
$146.22 - $169.13 $416,727 - $482,020
-2,850 Reduced 8.98%
28,882 $4.28 Million
Q2 2020

Aug 13, 2020
SELL
$136.42 - $164.18 $233,278 - $280,747
-1,710 Reduced 5.11%
31,732 $5.21 Million
Q1 2020

May 08, 2020
SELL
$119.05 - $147.35 $206,551 - $255,652
-1,735 Reduced 4.93%
33,442 $4.64 Million
Q4 2019

Feb 11, 2020
SELL
$106.92 - $132.43 $16,572 - $20,526
-155 Reduced 0.44%
35,177 $4.62 Million
Q3 2019

Oct 24, 2019
SELL
$106.79 - $116.16 $179,513 - $195,264
-1,681 Reduced 4.54%
35,332 $3.95 Million
Q2 2019

Aug 15, 2019
SELL
$110.79 - $129.32 $465,871 - $543,790
-4,205 Reduced 10.2%
37,013 $4.1 Million
Q1 2019

May 15, 2019
SELL
$111.31 - $131.02 $324,134 - $381,530
-2,912 Reduced 6.6%
41,218 $5.35 Million
Q4 2018

Aug 28, 2019
BUY
$105.9 - $118.64 $291,225 - $326,260
2,750 Added 6.65%
44,130 $5.11 Million
Q4 2018

Feb 15, 2019
SELL
$105.9 - $118.64 $184,901 - $207,145
-1,746 Reduced 4.05%
41,380 $4.79 Million
Q3 2018

Aug 28, 2019
BUY
$85.86 - $107.31 $236,115 - $295,102
2,750 Added 6.81%
43,126 $4.63 Million
Q3 2018

Nov 15, 2018
SELL
$85.86 - $107.31 $262,989 - $328,690
-3,063 Reduced 7.05%
40,376 $4.33 Million
Q2 2018

Aug 28, 2019
BUY
$75.7 - $86.88 $208,175 - $238,920
2,750 Added 6.76%
43,439 $3.71 Million
Q2 2018

Aug 14, 2018
SELL
$75.7 - $86.88 $229,673 - $263,593
-3,034 Reduced 6.94%
40,689 $3.47 Million
Q1 2018

Aug 28, 2019
BUY
$74.21 - $87.6 $204,077 - $240,899
2,750 Added 6.71%
43,723 $3.38 Million
Q1 2018

May 15, 2018
SELL
$74.21 - $87.6 $217,064 - $256,229
-2,925 Reduced 6.66%
40,973 $3.17 Million
Q4 2017

Aug 28, 2019
BUY
$81.94 - $87.89 $225,335 - $241,697
2,750 Added 6.68%
43,898 $3.71 Million
Q4 2017

Feb 15, 2018
SELL
$81.94 - $87.89 $269,336 - $288,894
-3,287 Reduced 7.4%
41,148 $3.48 Million
Q3 2017

Nov 14, 2017
BUY
$77.07 - $85.54 $3.42 Million - $3.8 Million
44,435
44,435 $3.8 Million

Others Institutions Holding LLY

# of Institutions
4,470
Shares Held
779M
Call Options Held
16.9M
Put Options Held
12.6M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $820B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email